Ensemble
Main objective:
This study will be enrolling pregnant women to receive an investigational vaccine intended to evaluate the safety, reactogenicity and immunogenicity of AD26.COV2.S in newborns.
Who are we looking for?
- 20-36 weeks of pregnancy
- No major health problems in mother/fetus
- Interested in possible reduction of chance of COVID-19 in baby
- Willing to have infant followed for first year of life
What’s provided for duration of study:
- Investigational vaccine administered to mother
- Close follow-up of infant for 1 year
- Modest payments for visits pre/post birth
- Opportunity to help reduce incidence of COVID-19
If you would like additional information, please send us an email or give us a call!